Sign in

    Bingyu Chen • Citigroup Inc.

    Bingyu Chen is an Assistant Vice President and Healthcare Research Analyst at Citigroup Inc., specializing in healthcare sector coverage with a focus on pharmaceutical and biotechnology companies. He supports research on specific firms within the healthcare domain, contributing analytical insights to inform investment decisions, though comprehensive public performance metrics and company coverage lists are not currently available. Bingyu Chen began his finance career prior to joining Citi, advancing to his current role as Healthcare Research Assistant Vice President, where he is recognized for his research support and sector expertise. He holds professional credentials consistent with equity research roles, including industry-standard FINRA registration and securities licenses.

    Bingyu Chen's questions to 111 Inc (YI) leadership

    Bingyu Chen's questions to 111 Inc (YI) leadership • Q4 2024

    Question

    Bingyu Chen of Citigroup Inc., also known as Zoey, questioned the company's technological advancements in the past year, particularly in AI applications and whether it would be a key growth driver. She also asked about initiatives to reduce fulfillment costs and the budget allocated for AI investment.

    Answer

    Executive Haihui Wang detailed that technology initiatives drove a shift to a platform business model, highlighting a shared inventory system with JBP partners and franchised fulfillment centers, which now total 11 with 15 more planned. He noted AI-powered tools for price prediction and a ChatBI system are already in use. For fulfillment, costs were reduced by expanding the regional warehouse footprint to lower last-mile delivery costs and leveraging the Kunpeng network for efficient inventory distribution. Regarding AI investment, Wang stated the company is building a platform for AI agents to improve customer experience and acquisition, and is training all employees on AI applications.

    Ask Fintool Equity Research AI